# Locally Advanced NSCLC Treated With Radiochemotherapy: Phase 2 Study on the Value of a Stereotactic Boost

> **NCT06627738** · PHASE2 · RECRUITING · sponsor: **Centre Antoine Lacassagne** · enrollment: 42 (estimated)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **RADIATION:** Cyberknife irradiation

## Key facts

- **NCT ID:** NCT06627738
- **Lead sponsor:** Centre Antoine Lacassagne
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-10
- **Primary completion:** 2034-02
- **Final completion:** 2034-02
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2026-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06627738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06627738, "Locally Advanced NSCLC Treated With Radiochemotherapy: Phase 2 Study on the Value of a Stereotactic Boost". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT06627738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*